share_log

4: Statement of changes in beneficial ownership of securities-Director Farley Chele Chiavacci

4: Statement of changes in beneficial ownership of securities-Director Farley Chele Chiavacci

4:持股變動聲明-董事 Farley Chele Chiavacci
美股SEC公告 ·  06/11 17:58

Moomoo AI 已提取核心訊息

Conduit Pharmaceuticals Inc. (CDT.US) reported that Farley Chele Chiavacci, acquired 37,272 shares of common stock on June 11, 2024. The transaction was coded as 'A', indicating a grant, award, or other acquisition. Following this transaction, Chiavacci's direct holdings in the company total 52,272 shares. The acquisition was executed with the shares being held directly by Chiavacci, as per the filing details. The transaction underscores a positive movement in the insider's stake in the company, which can be an indicator of the company's future prospects.
Conduit Pharmaceuticals Inc. (CDT.US) reported that Farley Chele Chiavacci, acquired 37,272 shares of common stock on June 11, 2024. The transaction was coded as 'A', indicating a grant, award, or other acquisition. Following this transaction, Chiavacci's direct holdings in the company total 52,272 shares. The acquisition was executed with the shares being held directly by Chiavacci, as per the filing details. The transaction underscores a positive movement in the insider's stake in the company, which can be an indicator of the company's future prospects.
Conduit Pharmaceuticals Inc. (CDT.US) 報告稱,Farley Chele Chiavacci於2024年6月11日收購了37,272股普通股。本次交易被編碼爲“A”,表示授予、獎勵或其他收購。此次交易後,Chiavacci在該公司的直接持股總數爲52,272股。根據申報細節,該收購是由Chiavacci直接持有的股份執行的。本次交易突顯了內部人士在公司股份方面的積極動向,這可能是該公司未來前景的一個指標。
Conduit Pharmaceuticals Inc. (CDT.US) 報告稱,Farley Chele Chiavacci於2024年6月11日收購了37,272股普通股。本次交易被編碼爲“A”,表示授予、獎勵或其他收購。此次交易後,Chiavacci在該公司的直接持股總數爲52,272股。根據申報細節,該收購是由Chiavacci直接持有的股份執行的。本次交易突顯了內部人士在公司股份方面的積極動向,這可能是該公司未來前景的一個指標。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息